Principal Associate Scientist/Senior Principal Associate Scientist, Hit Identification and Biology
Dragonfly Therapeutics seeks an experienced and motivated Principal/Senior Principal Associate Scientist with a strong background in cell biology/immunology to support the discovery and development of cancer and autoimmune therapies. The successful candidate will work with Dragonfly’s Hit Identification Team developing cell reagents and performing functional screening assays. In addition, the candidate will assist the flow cytometry core manager with daily operations and maintenance. The individual will support the Biology group in the pre-clinical development of novel biologic drugs that promise to revolutionize disease treatment.
Responsibilities:
Qualifications:
About Dragonfly
Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel multispecific antibody technology to harness the body's immune system to bring breakthrough treatments to patients. In addition to its wholly owned clinical assets, Dragonfly has a deep pipeline of wholly owned preclinical candidates discovered using its proprietary platform, as well as productive collaborations with Merck, AbbVie, Gilead and Bristol Myers Squibb in a broad range of disease areas.
Our mission is to revolutionize disease treatment by inventing natural killer cell-based therapies for vastly improved patient outcomes. We believe in a small team with a big impact.